Home » GLAXOSMITHKLINE REACHES AGREEMENT TO UPDATE PRODUCT LABEL
GLAXOSMITHKLINE REACHES AGREEMENT TO UPDATE PRODUCT LABEL
New York: Pharmaceutical giant GlaxoSmithKline has reached an agreement to update its product label for its popular drug Advair
with a new warning that advises doctors to limit its use only to patients who are not controlled on other asthma drugs.
New
Kerala
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May